Skip to content

The Effect of Probiotics on the Clearance of the Human Papillomavirus and on Cytological Lesions Caused by the Virus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01097356
Enrollment
60
Registered
2010-04-01
Start date
2010-04-30
Completion date
2011-12-31
Last updated
2021-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV-related Cytological Abnormalities on PAP Smear (LSIL)

Brief summary

Aim: In this project proposition the investigators would like to examine the effect of immune modulation by probiotics on the clearance of HPV-infections. This study provides a model for viral infection but also for cancer precursors. This would be an excellent model (and the only possible short-term model) to examine an effect on cancer precursors. Cancer precursors (cytological abnormalities such as L-SIL) are a scientifically accepted surrogate endpoint for cervical cancer, for example in HPV-vaccine studies. Research question: Does daily intake of probiotics lead to a better immune-response in HPV-infected women, i.e. does it facilitate clearance of the virus and/or regression of cytological lesions?

Interventions

DIETARY_SUPPLEMENTprobiotic drinkers

HPV+, LSIL patients in this arm will drink the probiotic study drink for a period of 6 months

Sponsors

Universiteit Antwerpen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* women with a new LSIL diagnosis an HPV positivity on PAP smear

Exclusion criteria

* women over 65 * immunocompromised patients (because of disease or drugs)

Design outcomes

Primary

MeasureTime frame
1.proportion of HPV positives in both arms6months
2. proportion of regression of LSIL lesion in both arms6 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026